The genetically engineered NVs greatly improved tumor targeting and accumulation of the nanoparticles, and disruption of the PD1/PDL1 signaling pathway by PD1 greatly enhanced cancer immunotherapy by promoting T cell infiltration and antitumor immune responses. The gene discussed is CD274; the disease is neoplasm.